ConductScience.org, home

Paper52353

The effects of allopurinol and clofibrate on the elimination of coumarin anticoagulants in man.

Pond SM and 3 others. Aust N Z J Med, 1975. Cited by 24 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. The effects of allopurinol and clofibrate on the elimination of coumarin anticoagulants in man. Papers, record 52353. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/52353

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The effects of allopurinol and clofibrate on the elimination of coumarin anticoagulants in man.
PubMed
Journal
Aust N Z J Med
PubMed
Year
1975
PubMed
Publication types
Comparative Study, Journal Article
PubMed
Citations, by iCite
24
iCite
Relative citation ratio, by iCite
1.41
iCite
Revised in PubMed
2019-08-23
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Pond SMS M
2Graham GGG G
3Wade DND N
4Sudlow GG

Source PubMed

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AllopurinolMajor topic
ClofibrateMajor topic
DicumarolMajor topic
WarfarinMajor topic
Adult
Biological Availability
Blood Proteins
Butyrates
Half-Life
Humans
Male
Protein Binding

Source PubMed

Cited by7

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 24 citations.

PMIDTitleJournalYearIn PapersSource
42,539,118Patterns of deprescribing after an emergency department visit due to adverse drug events among concomitant users of antithrombotics and other medications.medRxiv2026https://conductscience.org/library/papers/42539118PubMed
23,616,817Bleeding complications and liver injuries during phenprocoumon treatment: a multicentre prospective observational study in internal medicine departments.Dtsch Arztebl Int2013https://conductscience.org/library/papers/23616817PubMed
6,347,619Drug interactions with warfarin.Drugs1983https://conductscience.org/library/papers/6347619PubMed
6,147,220Pharmacokinetic drug interactions with theophylline.Clin Pharmacokinet1984https://conductscience.org/library/papers/6147220PubMed
925,883Interaction of clofibrate with warfarin. I. Effect of clofibrate on the disposition of the optical enantiomorphs of warfarin.J Pharmacokinet Biopharm1977https://conductscience.org/library/papers/925883PubMed
391,530Antiplatelet drugs: clinical pharmacology and therapeutic use.Drugs1979https://conductscience.org/library/papers/391530PubMed
338,281Interindividual differences in the response to oral anticoagulants.Drugs1977https://conductscience.org/library/papers/338281PubMed

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/52353

GET https://conductscience.org/api/papers/v1/52353/authors